Dr JianJun Gao discusses papillary renal cell carcinoma (pRCC) and prospective immunotherapy

At the Thirteenth International Kidney Cancer Symposium, Dr JianJun Gao (The University of Texas MD Anderson Cancer Center, TX) discusses papillary renal cell carcinoma (pRCC) and prospective immunotherapy.

pRCC is a relatively uncommon subtype of renal cell carcinoma (RCC) that is distinct from the more common clear cell RCC subtype. It is possible that progress in immunotherapeutic research in clear cell RCC that target common components of the immune system may be clinically applicable for patients with pRCC.